Carissa Dukes
Director - Global Epidemiology & Real World Evidence Boehringer Ingelheim
Carissa Dukes is an established epidemiologist with over a decade of experience in real-world evidence (RWE), specializing in mental health and the integration of observational data into clinical research. Her work has generated impactful insights that inform the development of patient-centered treatments and improve quality of life for individuals with psychiatric conditions.
Carissa leads strategic initiatives bridging the gap between clinical trials and real-world practice, accelerating clinical adoption through evidence-based innovation. She is a recognized leader in tokenization, having played a pivotal role in its implementation across her organization. She chairs a cross-functional working group and steering committee, focused on developing governance frameworks and ethical guidance for tokenization.
Her efforts have been instrumental secure, scalable use of real-world data across disparate systems, highlighting the patient journey while maintaining data integrity and confidentiality. Carissa brings a unique blend of scientific rigor, operational leadership, and ethical foresight to the evolving RWE landscape.
Seminars
- Learn how tokenisation enables secure patient-level linkage across trial and real-world datasets in the European legal/regulatory context
- Explore practical use cases of data fusion to strengthen causal inference and expand trial relevance and evaluate fit for purpose datasets in Europe for tokenisation linkage
- Discuss challenges in implementing tokenisation in Europe vs. the U.S., and where the opportunities lie for pharma
